Register for our free email digests:
 |
David WallaceManaging Editor |
Generics Bulletin Managing Editor Dave Wallace has nearly 10 years experience of reporting on the global generic, biosimilar, value-added and OTC medicines industries. Having previously worked in the European chemicals industry, Dave has now spent almost a decade with Generics Bulletin. Bringing his background and education in law to bear on industry litigation - as well as national legislative and regulatory affairs - he also keeps a close eye on corporate strategy, personnel moves, and product pipelines. A regular delegate to industry events and conferences, he has a particular interest in local market developments, maintaining close links with national industry representatives. He also organizes and judges the annual Global Generics & Biosimilars Awards. A French speaker, Dave enjoys music - with a love of the piano - and visual arts. |
 |
Aidan FryExecutive Editor |
As the co-founder of Generics Bulletin, Aidan has 20 years of reporting in detail on the global generic, biosimilar, value-added and OTC medicines industries. With over 20 years of experience of reporting on the global pharmaceutical industry, Aidan focuses in his role as executive editor of Generics Bulletin particularly on commercial, regulatory and legal issues affecting the generic, biosimilar, value-added and OTC medicines industries. This includes in-depth analyses of corporate strategy, legislative changes, legal precedents and product perspectives. He regularly interviews leading industry executives and moderates prestigious events. Aidan also oversees the Global Generics & Biosimilars Awards. Aidan speaks fluent German and has a particular affection for maps. |
|
|
||
 |
Dean RudgeAssistant Editor |
Joining the Generics Bulletin team in 2013, Dean has five years of experience reporting on the global generic, biosimilar and value-added medicines industries. Dean has built up a wealth of knowledge on the global generics and biosimilar medicines industries in his five years with Generics Bulletin. He specializes in commercial and legal issues, writing in-depth analyses of corporate strategy and getting under the skin of patent infringement proceedings and other litigation. He attends investor and regulatory meetings with business leaders, favoring the investor days with their focus on corporate strategy. In his spare time, Dean enjoys visiting museums and playing five-a-side football. |
 |
Grace MontgomeryBusiness Reporter |
Grace has just over two years of experience reporting on the global generic and biosimilar medicines industries, after joining Generics Bulletin as business reporter in 2016. Having built up two years knowledge of the global pharmaceutical industry, Grace reports on a wide range of topics including companies' business strategies, regulatory affairs, market research and product pipelines. Along with story sourcing, she particularly enjoys analyzing industry reports and highlighting companies' corporate business plans, and has attended industry conferences to network and attain exclusive content. Grace enjoys puzzles, baking and keeping active. |
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.